Acute delirium after withdrawal of amantadine in Parkinson's disease
- PMID: 9596005
- DOI: 10.1212/wnl.50.5.1456
Acute delirium after withdrawal of amantadine in Parkinson's disease
Abstract
We present three patients who, after long-term therapy with amantadine (4 to 18 years), experienced an acute delirium with confusion, disorientation, agitation, and paranoia on withdrawal. These patients had Parkinson's disease for 5 to 29 years; mean age was 73 years. All had a history of varying degrees of dementia and transient hallucinations in the past. Adjustment of other medications was ineffective in improving their condition and no other cause was found. Only with reinstitution of amantadine did the patients return to baseline status (usually within days).
Comment in
-
New lessons from old drugs: amantadine and Parkinson's disease.Neurology. 1998 May;50(5):1211-2. doi: 10.1212/wnl.50.5.1211. Neurology. 1998. PMID: 9595964 Clinical Trial. No abstract available.
-
Acute delirium after withdrawal of amantadine in Parkinson's disease.Neurology. 1999 May 12;52(8):1720-1. doi: 10.1212/wnl.52.8.1717-d. Neurology. 1999. PMID: 10331717 No abstract available.
Similar articles
-
Acute delirium after withdrawal of amantadine in Parkinson's disease.Neurology. 1999 May 12;52(8):1720-1. doi: 10.1212/wnl.52.8.1717-d. Neurology. 1999. PMID: 10331717 No abstract available.
-
Visual hallucinations and delirium during treatment with amantadine (Symmetrel).J Am Geriatr Soc. 1975 May;23(5):212-5. doi: 10.1111/j.1532-5415.1975.tb00187.x. J Am Geriatr Soc. 1975. PMID: 123540
-
Plasma amantadine concentrations in patients with Parkinson's disease.Parkinsonism Relat Disord. 2009 Jun;15(5):351-3. doi: 10.1016/j.parkreldis.2008.08.005. Epub 2008 Sep 27. Parkinsonism Relat Disord. 2009. PMID: 18823813
-
Amantadine in Parkinson's disease: pro and contra.J Neural Transm Suppl. 1995;46:415-21. J Neural Transm Suppl. 1995. PMID: 8821077 Review.
-
Possible use of amantadine in depression.Pharmacopsychiatry. 1999 Mar;32(2):47-55. doi: 10.1055/s-2007-979191. Pharmacopsychiatry. 1999. PMID: 10333162 Review.
Cited by
-
High dose amantadine therapy may cause increased falling in patients with Parkinson's disease: A case report.Clin Park Relat Disord. 2020 Feb 22;3:100045. doi: 10.1016/j.prdoa.2020.100045. eCollection 2020. Clin Park Relat Disord. 2020. PMID: 34316630 Free PMC article. No abstract available.
-
Implications of dopaminergic medication withdrawal in Parkinson's disease.J Neural Transm (Vienna). 2022 Sep;129(9):1169-1178. doi: 10.1007/s00702-021-02389-x. Epub 2021 Jul 29. J Neural Transm (Vienna). 2022. PMID: 34324057 Free PMC article.
-
A Case Report of Severe Delirium after Amantadine Withdrawal.Case Rep Neurol. 2017 Mar 20;9(1):44-48. doi: 10.1159/000460814. eCollection 2017 Jan-Apr. Case Rep Neurol. 2017. PMID: 28611642 Free PMC article.
-
Management of Parkinson's disease dementia : practical considerations.Drugs Aging. 2006;23(10):807-22. doi: 10.2165/00002512-200623100-00004. Drugs Aging. 2006. PMID: 17067184 Review.
-
Case files of the program in medical toxicology at brown university: amantadine withdrawal and the neuroleptic malignant syndrome.J Med Toxicol. 2009 Jun;5(2):92-8. doi: 10.1007/BF03161096. J Med Toxicol. 2009. PMID: 19415596 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous